Samorita Hospital (DHA:SAMORITA) ROE %: 0.00% (As of . 20)


DHA:SAMORITA Samorita Hospital Ltd DHA:SAMORITA
18 GF Score
Price BDT76.80
! 1 Warning Sign
View Full Analysis

What is Samorita Hospital ROE %?

Samorita Hospital DHA:SAMORITA +3.09% 18 ROE % is 0.00% as of . 20. GuruFocus rates DHA:SAMORITA with a GF Score™ of 18/100. The stock has 1 warning sign investors should review. Among 628 Healthcare Providers & Services companies, Samorita Hospital ranks worse than 159235.51% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Samorita Hospital's annualized net income for the quarter that ended in . 20 was BDT Mil. Samorita Hospital's average Total Stockholders Equity over the quarter that ended in . 20 was BDT Mil. Therefore, Samorita Hospital's annualized ROE % for the quarter that ended in . 20 was %.

The historical rank and industry rank for Samorita Hospital's ROE % or its related term are showing as below:

DHA:SAMORITA's ROE % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 5.72
* Ranked among companies with meaningful ROE % only.

Samorita Hospital  (DHA:SAMORITA) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: . 20 )
=Net Income/Total Stockholders Equity
=/
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=( / )*( / )*( / )
=Net Margin %*Asset Turnover*Equity Multiplier
= %**
=ROA %*Equity Multiplier
= %*
= %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: . 20 )
=Net Income/Total Stockholders Equity
=/
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= ( / ) * ( / ) * ( / ) * ( / ) * ( / )
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= * * % * *
= %

Note: The net income data used here is one times the annual (. 20) net income data. The Revenue data used here is one times the annual (. 20) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Samorita Hospital ROE % Related Terms


Samorita Hospital ROE % Historical Data

* Premium members only.

The historical data trend for Samorita Hospital's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Samorita Hospital ROE % Chart

Samorita Hospital Annual Data
Trend
ROE %

Samorita Hospital Semi-Annual Data
ROE %

DHA:SAMORITA vs SPIN, USNU, CHCR: ROE % Comparison

For the Medical Care Facilities subindustry, Samorita Hospital's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Samorita Hospital ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Samorita Hospital's ROE % distribution charts can be found below:

* The bar in red indicates where Samorita Hospital's ROE % falls into.


DHA:SAMORITA
18GF Score
Samorita Hospital Ltd DHA:SAMORITA
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Samorita Hospital ROE % Calculation

Samorita Hospital's annualized ROE % for the fiscal year that ended in . 20 is calculated as

ROE %=Net Income (A: . 20 )/( (Total Stockholders Equity (A: . 20 )+Total Stockholders Equity (A: . 20 ))/ count )
=/( (+)/ )
=/
= %

Samorita Hospital's annualized ROE % for the quarter that ended in . 20 is calculated as

ROE %=Net Income (Q: . 20 )/( (Total Stockholders Equity (Q: . 20 )+Total Stockholders Equity (Q: . 20 ))/ count )
=/( (+)/ )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is one times the annual (. 20) net income data. ROE % is displayed in the 30-year financial page.

* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 0.00% mean?
Samorita Hospital (DHA:SAMORITA) has a ROE % of 0.00% as of . 20. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Samorita Hospital and its competitors. According to the industry distribution chart, Samorita Hospital ranks #999999 out of 628 companies in the Healthcare Providers & Services industry.
Is Samorita Hospital's ROE % too high?
Samorita Hospital's current ROE % is 0.00%. Based on the distribution chart, Samorita Hospital ranks #999999 out of 628 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Samorita Hospital has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Samorita Hospital's ROE % compare to SPIN and USNU?
According to the Healthcare Providers & Services industry distribution chart, Samorita Hospital ranks #999999 out of 628 companies for ROE %. This places Samorita Hospital in the lower half of its industry. The industry median ROE % is 5.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.72, based on 628 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Samorita Hospital and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Samorita Hospital's current ROE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Samorita Hospital stock overvalued right now?
Samorita Hospital (DHA:SAMORITA) has a current ROE % of 0.00%. The current ROE % is 0.00%. Samorita Hospital's overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Samorita Hospital (DHA:SAMORITA), the current ROE % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Samorita Hospital Business Description

Address 89/1 Panthapath, Dhaka, BGD, 1215
Samorita Hospital Ltd provides general hospital services including all types of medical treatment along with diagnostic services in Bangladesh. It offers various clinical services in the areas of internal medicine, neurology, diabetes and endocrinology, nephrology, respiratory medicine, gastroenterology and other.
18GF Score

Get the complete analysis for DHA:SAMORITA

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT76.80
Price